Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Reclassification of medicines from prescription to non-prescription availability without industry sponsorship: two case studies

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Poster
  • By: GAULD, Natalie (University of Auckland, Auckland, New Zealand)
  • Co-author(s): Emmerton, Lynne (University of Queensland, BRISBANE, Australia)
    Kelly, Fiona (University of Auckland, AUCKLAND, New Zealand)
    Bryant, Linda (University of Auckland, AUCKLAND, New Zealand)
    Buetow, Stephen (University of Auckland, AUCKLAND, New Zealand)
  • Abstract:

    Background: Traditionally, reclassification of medicines from prescription to non-prescription has been initiated by pharmaceutical companies. However, industry support was not forthcoming regarding reclassification of chloramphenicol and calcipotriol in New Zealand (NZ). Potential consumer benefits of easier access to such medicines may require

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses